| Tracheophyta| Tracheophyta Sinnott ex Cavalier-Smith, 1998| vascular plants
Nutritional Value: Many plants within Tracheophyta are important sources of nutrition for humans. Fruits, vegetables, grains, and nuts from vascular plants provide essential vitamins, minerals, fiber, and other nutrients.
Medicinal Uses: Numerous plant species within Tracheophyta have been used in traditional medicine and modern pharmacology. Certain plants contain bioactive compounds with potential therapeutic properties.
Oxygen Production: Like all plants, Tracheophyta contributes to oxygen production through photosynthesis. Oxygen is essential for human and animal respiration.
Carbon Sequestration: Trees and other vascular plants contribute to carbon sequestration, helping to mitigate climate change by absorbing carbon dioxide from the atmosphere.
Ecosystem Services: Vascular plants provide various ecosystem services, including soil stabilization, water purification, and habitat provision. Forests, in particular, are critical for biodiversity and ecological balance.
Wood and Fiber Production: Vascular plants are a major source of wood and fibers used in construction, paper production, and various industries.
Ornamental Plants: Many vascular plants are cultivated for ornamental purposes, enhancing the aesthetics of gardens, parks, and landscapes. Exposure to natural environments with vascular plants has been linked to improved mental well-being.
Allergies: Pollen from certain vascular plants can trigger allergies in sensitive individuals, causing respiratory or skin reactions.
Biodiversity: Vascular plants contribute to biodiversity, supporting a wide array of species in terrestrial ecosystems.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.97 | 6 | 1192 | 0 | 933 | 271.3 | 120 | 337.5 | 0 | 620 | 0 %ile | 100 %ile | ||
biomesight | 24.39 | 0 | 10 | 10 | 190 | 0 | 3334 | 148.7 | 30 | 1625.4 | 10 | 70 | 0 %ile | 95.4 %ile |
thryve | 0.99 | 10 | 138 | 0 | 118 | 44.2 | 31 | 37.8 | 10 | 138 | 7.7 %ile | 84.6 %ile | ||
ubiome | 2.28 | 22 | 557 | 0 | 424 | 124.9 | 52 | 152.4 | 22 | 557 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 25.393 % | 0.013 % | 0.147 % | 727.0 | 2863 |
BiomeSightRdp | 71.875 % | 0.02 % | 0.027 % | 23.0 | 32 |
es-xenogene | 3.448 % | 0.003 % | % | 1.0 | 29 |
Medivere | 42.857 % | 0.003 % | 0.002 % | 3.0 | 7 |
SequentiaBiotech | 5.556 % | 0.075 % | 0.063 % | 2.0 | 36 |
Thorne | 17.045 % | 0 % | 0 % | 15.0 | 88 |
Thryve | 0.795 % | 0.004 % | 0.004 % | 11.0 | 1383 |
uBiome | 2.273 % | 0.012 % | 0.015 % | 18.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.